Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model

Journal of Magnetic Resonance Imaging

Volumn 13, Issue 6, 2001, Pages 882-888

  Turetschek, Karl ^a,b   Roberts, Timothy P L ^a   Floyd, Eugenia ^c   Preda, Anda ^a   Novikov, Viktor ^a   Shames, David M ^a   Carter, Wayne O ^c   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Breast neoplasms; Contrast media; Histologic tumor grade; Magnetic resonance imaging; Microvascular density

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MODEL; FEMALE; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

ALBUMINS; ANIMALS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; FEMALE; GADOLINIUM DTPA; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROCIRCULATION; OXIDES; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 0035019579     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1126     Document Type: Article

References (26)

1. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 1989;64:1914-1921.
2. Harris AL, Zhang H, Moghaddam A, et al. Breast cancer angiogenesis - new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 1996;38:97-108.
3. Goede V, Fleckenstein G, Dietrich M, Osmers RG, Kuhn W, Augustin HG. Prognostic value of angiogenesis in mammary tumors. Anticancer Res 1998;18:2199-2202.
4. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Am J Roentgenol 1998;171:941-949.
5. Su MY, Najafi AA, Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34:402-411.
6. Gossmann A, Okuhata Y, Shames DM, et al. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media - preliminary experience. Radiology 1999;213:265-272.
7. Turetschek K, Huber S, Floyd E, et al. MRI characterization of microvessels in experimental breast tumors using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218:562-569.
8. Schwickert HC, Stiskal M, van Dijke CF, et al. Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent. Acad Radiol 1995;2:851-858.
9. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
10. Stoica G, Koestner A, Capen C. Neoplasms induced with high single doses of N-ethyl-N-nitrosurea in 30 day-old sprague dawley rats, with special emphasis in mammary neoplasia. Anticancer Res 1984;4:5-12.
11. Stoica G, Koestner A. Diverse spectrum of tumors in male sprague dawley rats following single high doses of N-ethyl-N-nitrosurea (ENU). Am J Path 1984:319-325.
12. Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34:845-852.
13. Ogan M, Schmiedl U, Moseley M, Grodd W, Paajenen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987;22:665-671.
14. Schmiedl U, Ogan M, Moseley M, et al. Comparison of the contrastenhancing properties of Albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. Am J Roentgenol 1986;147:1263-1270.
15. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90.
16. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging - a quantitative noninvasive technique. Magn Reson Med 1993;29:616-622.
17. Scarff R, Torloni H. Histological typing of breast tumors. World Health Organization, Geneva, Switzerland. 1968:13-20.
18. Bloom H, Richardson W. Histologic grading and prognosis in breast cancer. Br J Cancer 1957;11:359-377.
19. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214.
20. Engelbrecht MR, Saeed M, Wendland MF, Canet E, Oksendal AN, Higgins CB. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media. J Magn Reson Imaging 1998;8:616-621.
21. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
22. Bremerich J, Roberts TPL, Wendland M, et al. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 (Clariscan). J Magn Reson Imaging 2000;11:622-628.
23. Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998;8:1198-1204.
24. Harisinghani MG, Saini S, Weissleder R, et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. Am J Roentgenol 1999;172:1347-1351.
25. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
26. de Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36:306-312.